Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027329
Filing Date
2024-11-20
Accepted
2024-11-20 16:02:46
Documents
1
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 form4-11202024_091142.html 4  
1 form4-11202024_091142.xml 4 3396
  Complete submission text file 0001415889-24-027329.txt   5054
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O ONCONOVA THERAPEUTICS 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
MARINO JAMES J (Reporting) CIK: 0001198578 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 241480291